Updates and advances in multiple sclerosis neurotherapeutics

Area of Science:

• Neuroscience
• Immunology
• Pharmacology

Background:

• The therapeutic landscape for multiple sclerosis (MS) is rapidly evolving.
• New disease-modifying therapies (DMTs) offer improved efficacy and safety for MS patients.
• Existing DMTs effectively manage MS neuroinflammation.

Purpose of the Study:

• To summarize recent updates in multiple sclerosis neurotherapeutics.
• To highlight ongoing research in drug discovery for progressive MS.
• To review emerging agents for remyelination and neuroprotection.

Main Methods:

• Literature review of recent advancements in MS therapies.
• Analysis of the current DMT armamentarium.
• Examination of emerging research pipelines for novel MS treatments.

Main Results:

• An expanding pipeline of DMTs with novel mechanisms is available for MS.
• Concerted efforts are focused on identifying targets for progressive MS and drug discovery.
• Research is progressing on agents for remyelination and neuroprotection.

Conclusions:

• Further insights are needed to guide DMT initiation and sequencing in MS.
• The role of autologous stem cell transplantation in relapsing and progressive MS requires further determination.
• The evolving neurotherapeutic landscape offers increased options for managing MS.